The global industry for therapeutics targeting IgG4-related disease is witnessing substantial growth. Driven by an rising prevalence of these immunological conditions and the introduction of novel treatment solutions, the market is poised for significant prospects in the foreseeable future. Key factors fueling this growth include a growing under… Read More